The PEARRL project officially started on May 1st and will be running for the next three years. The objectives of the PEARRL research programme are to deliver novel bio-enabling formulations and new biopharmaceutics tools to predict their in vivo performance as a means to improve efficiency and cost-competitiveness in drug development, thus facilitating earlier access of patients to “breakthrough therapies”.
In order to have a successful start to the project the PEARRL partners along with the recruited ESRs from all over Europe are meeting up to discuss the next steps in the project. The Consortum Meeting will be held on the October 31st at our partner, Johann Wolfgang Goethe University. We are looking forward to meeting all participants involved in PEARRL.
Klick here for the agenda
Klick here for the agenda
RSS Feed
